Related references
Note: Only part of the references are listed.Rituximab for IgG4-related disease: a prospective, open-label trial
Mollie N. Carruthers et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Projected Worldwide Disease Burden from Giant Cell Arteritis by 2050
Elisabeth De Smit et al.
JOURNAL OF RHEUMATOLOGY (2015)
Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis
Lindsay Lally et al.
RHEUMATOLOGY (2015)
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis
Sarah Louise Mackie et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis
Marc Corbera-Bellalta et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression
Suchita Nadkarni et al.
CIRCULATION RESEARCH (2014)
Tocilizumab: a new therapy for large vessel vasculitis
Ibrahim A. Al-Homood
CLINICAL AND EXPERIMENTAL MEDICINE (2014)
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis
M. Yates et al.
CLINICAL RHEUMATOLOGY (2014)
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
Enrica Golia et al.
CURRENT ATHEROSCLEROSIS REPORTS (2014)
Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis
Mattia Baldini et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Interleukin-1 blockade in refractory giant cell arteritis
Kim-Heang Ly et al.
JOINT BONE SPINE (2014)
2. Epidemiology of giant cell arteritis: a critical review
R. A. Watts
RHEUMATOLOGY (2014)
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis
Marco A. Alba et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Disturbed B Cell Homeostasis in Newly Diagnosed Giant Cell Arteritis and Polymyalgia Rheumatica
Kornelis S. M. van der Geest et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The Thromboembolic Risk in Giant Cell Arteritis: A Critical Review of the Literature
A. Guida et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2014)
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Maricica Pacurari et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2014)
Aspirin as adjunctive treatment for giant cell arteritis (Review)
Susan P. Mollan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Immune mechanisms in medium and large-vessel vasculitis
Cornelia M. Weyand et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study
Yvan Jamilloux et al.
PLOS ONE (2013)
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review
Hubert de Boysson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series
Andreas P. Diamantopoulos et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Design of the Tocilizumab in Giant Cell Arteritis Trial
Sebastian H. Unizony et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2013)
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumaticae
N. T. Baerlecken et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
Maxime Samson et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series
T. Adizie et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Clinical features of polymyalgia rheumatica and giant cell arteritis
Carlo Salvarani et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Role of oral cyclophosphamide in the treatment of giant cell arteritis
Luca Quartuccio et al.
RHEUMATOLOGY (2012)
Notch receptor-ligand binding and activation: Insights from molecular studies
Chandramouli R. Chillakuri et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases
Savino Sciascia et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells
Abbe N. Vallejo et al.
AGEING RESEARCH REVIEWS (2011)
Nod1 Ligands Induce Site-Specific Vascular Inflammation
Hisanori Nishio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Blocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis
Kisha Piggott et al.
CIRCULATION (2011)
IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis
Cornelia M. Weyand et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis-a prospective longitudinal study
Sudha Visvanathan et al.
RHEUMATOLOGY (2011)
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
Jiusheng Deng et al.
CIRCULATION (2010)
Increased Tissue Endothelin-1 and Endothelin-B Receptor Expression in Temporal Arteries from Patients with Giant Cell Arteritis
Ivan Dimitrijevic et al.
OPHTHALMOLOGY (2010)
BSR and BHPR guidelines for the management of giant cell arteritis
Bhaskar Dasgupta et al.
RHEUMATOLOGY (2010)
Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis
Jiusheng Deng et al.
CIRCULATION RESEARCH (2009)
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis:: A cross-sectional screening of fifty-four prospectively followed patients
Ana Garcia-Martinez et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Vessel-specific Toll-like receptor profiles in human medium and large arteries
Olga Pryshchep et al.
CIRCULATION (2008)
Neuro-ophthalmic complications in giant cell arteritis
Frances A. Borg et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2008)
Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor
Lorenzo Cosmi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses
Elisabetta Volpe et al.
NATURE IMMUNOLOGY (2008)
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
V. M. Martinez-Taboada et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?
D. Makkuni et al.
RHEUMATOLOGY (2008)
Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis
E. Lozano et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Gelatinase expression and proteolytic activity in giant-cell arteritis
Marta Segarra et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Risk factors for early visual deterioration in temporal arteritis
Tobias Loddenkemper et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Adjunctive methotrexate for treatment of giant cell arteritis -: An individual patient data meta-analysis
Alfred D. Mahr et al.
ARTHRITIS AND RHEUMATISM (2007)
Treatment of refractory temporal arteritis with adalimumab
M. Mubashir Ahmed et al.
CLINICAL RHEUMATOLOGY (2007)
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial
Gary S. Hoffman et al.
ANNALS OF INTERNAL MEDICINE (2007)
The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab
B. Mayrbaeurl et al.
CLINICAL RHEUMATOLOGY (2007)
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
A Bhatia et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis
D Foell et al.
JOURNAL OF PATHOLOGY (2004)
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
MJH Nicklin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
